Exencial Wealth Advisors, LLC Editas Medicine, Inc. Transaction History

Exencial Wealth Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$26.55 - $40.57 $176,424 - $269,587	-6,645 Closed	0 $0
Q3 2021 Nov 04, 2021	SELL	$39.27 - $72.94 $194,622 - $361,490	-4,956 Reduced 42.72%	6,645 $273,000
Q2 2021 Aug 16, 2021	BUY	$31.29 - $56.64 $177,977 - $322,168	5,688 Added 96.19%	11,601 $657,000
Q1 2021 May 06, 2021	SELL	$39.71 - $90.58 $22,436 - $51,177	-565 Reduced 8.72%	5,913 $248,000
Q4 2020 Feb 11, 2021	BUY	$27.07 - $84.35 $175,359 - $546,419	6,478 New	6,478 $454,000

227

54.2M

412K

355K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $107M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Exencial Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Exencial Wealth Advisors, LLC with notifications on news.